Coya Therapeutics is headquartered in Houston, Texas, within the United States. Its primary corporate offices and research coordination hubs direct its administrative functions, partner collaborations, and the clinical development of its advanced regulatory T cell-modulating therapeutic candidates across multiple research institutions.